TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post
press enter to search

LOG IN / REGISTER
The Jakarta Post - Logo Mobile

Popular Reads

No popular reads data found

Top Results

No results found. Please check your search term and try again

Can't find what you're looking for?

View all search results

Popular Reads

No popular reads data found

Top Results

No results found. Please check your search term and try again

Can't find what you're looking for?

View all search results

chloroquine-drugs

Global COVID-19 prevention trial of hydroxychloroquine to resume
World 5 years ago

Global COVID-19 prevention trial of hydroxychloroquine to resume

A global trial designed to test whether the anti-malaria drugs hydroxychloroquine and chloroquine can prevent infection with COVID-19 is to restart after being approved by British regulators.
Trump critical of FDA decision to revoke emergency use of drug he has promoted for COVID-19
World 5 years ago

Trump critical of FDA decision to revoke emergency use of drug he has promoted for COVID-19

The US Food and Drug Administration on Monday revoked its emergency use authorization for hydroxychloroquine to treat COVID-19, but quickly came under fire from President Donald Trump, who said only US agencies have failed to grasp its benefit in fighting the coronavirus.
'No benefit' from hydroxychloroquine for virus: UK trial
World 5 years ago

'No benefit' from hydroxychloroquine for virus: UK trial

Hydroxychloroquine, a decades-old malaria and rheumatoid arthritis drug, has been touted as a possible treatment for the new coronavirus by high profile figures, including US President Donald Trump, and has been included in several randomized clinical trials.
WHO trial suspends hydroxychloroquine treatment for new COVID-19 patients
National 5 years ago

WHO trial suspends hydroxychloroquine treatment for new COVID-19 patients

According to a Health Ministry Research and Development Agency (Balitbangkes) letter addressed to the Indonesian Solidarity Trial research team, "hydroxychloroquine randomization for new subjects is suspended".
WHO expects hydroxychloroquine safety findings by mid-June
World 5 years ago

WHO expects hydroxychloroquine safety findings by mid-June

"A final decision on the harm, benefit or lack of benefit of hydroxychloroquine will be made once the evidence has been reviewed," the body said. "It is expected by mid-June."
Indonesia, major advocate of hydroxychloroquine, told by WHO to stop using it
World 5 years ago

Indonesia, major advocate of hydroxychloroquine, told by WHO to stop using it

Indonesian companies have made millions of doses
Brazil stands by hydroxychloroquine despite WHO
World 5 years ago

Brazil stands by hydroxychloroquine despite WHO

Brazil's health ministry said Monday it would not change its recommendation to treat coronavirus with hydroxychloroquine, despite the World Health Organization deciding to suspend trials of the drug over safety concerns.
US vaccine expert says he was removed for opposing Trump-backed chloroquine
World 5 years ago

US vaccine expert says he was removed for opposing Trump-backed chloroquine

The head of the US agency in charge of developing a vaccine against coronavirus said Wednesday that he was removed from his job for opposing the chloroquine treatment promoted by President Donald Trump.
No benefit, higher death rate for malaria drug in coronavirus study
World 5 years ago

No benefit, higher death rate for malaria drug in coronavirus study

A malaria drug widely touted as a potential cure for COVID-19 showed no benefit against the disease over standard care -- and was in fact associated with more deaths, the biggest study of its kind showed Tuesday.
Africans rush for chloroquine as virus tsunami looms
World 5 years ago

Africans rush for chloroquine as virus tsunami looms

Despite loud appeals for caution, Africans are rushing to embrace chloroquine, the venerable anti-malaria drug touted as a possible treatment for coronavirus.
The Jakarta Post - Premium Subscription Banner
The Jakarta Post
The Jakarta Post - Apps Store Icon The Jakarta Post - Google Play Icon

© 2016 - 2026 PT. Bina Media Tenggara

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Enter at least 30 characters
0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.